slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
20.300 KRW | +0,25% | +2,99% | -3,33% |
Vakgebied
Aantal werknemers: 532
Verkoop per activiteit
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Next Generation Sequencing
55,6
%
| 76 516 | 55,2 % | 73 879 | 55,6 % | -3,45% |
Capillary Electrophoresis Sequencing
25,3
%
| 32 814 | 23,7 % | 33 640 | 25,3 % | +2,52% |
Others
9,0
%
| 16 188 | 11,7 % | 11 929 | 9,0 % | -26,31% |
Genome Applications
7,6
%
| 10 872 | 7,8 % | 10 045 | 7,6 % | -7,61% |
Clinical Diagnosis
2,5
%
| 2 227 | 1,6 % | 3 309 | 2,5 % | +48,60% |
Verkoop per regio
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
South Korea
52,4
%
| 70 514 | 50,9 % | 69 533 | 52,4 % | -1,39% |
Europe
16,9
%
| 21 492 | 15,5 % | 22 469 | 16,9 % | +4,54% |
Other Countries
15,2
%
| 22 871 | 16,5 % | 20 184 | 15,2 % | -11,75% |
Japan
14,2
%
| 21 828 | 15,7 % | 18 836 | 14,2 % | -13,71% |
Australia
0,7
%
| 1 437 | 1,0 % | 993 | 0,7 % | -30,95% |
United States
0,6
%
| 474 | 0,3 % | 790 | 0,6 % | +66,52% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Su-Gang Lee
CEO | Chief Executive Officer | 58 | - |
Jong-Yeon Shin
CTO | Chief Tech/Sci/R&D Officer | 51 | - |
Chang-Hoon Kim
BRD | Director/Board Member | 57 | - |
Hyung-Tae Kim
BRD | Director/Board Member | 61 | - |
Han-Joon Bae
SAM | Sales & Marketing | 52 | - |
Eung-Ryong Lee
PRN | Corporate Officer/Principal | 51 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jeong-Sun Seo
CHM | Chairman | 71 | - |
Hyung-Tae Kim
BRD | Director/Board Member | 61 | - |
Hee-Min Kwon
BRD | Director/Board Member | 72 | - |
Chang-Hoon Kim
BRD | Director/Board Member | 57 | - |
Jong-Il Kim
BRD | Director/Board Member | 57 | - |
Jin-Woo Park
BRD | Director/Board Member | 72 | 24-03-17 |
Su-Gang Lee
CEO | Chief Executive Officer | 58 | - |
Do-Ho Lee
BRD | Director/Board Member | 75 | - |
Ha-Young Park
BRD | Director/Board Member | 68 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 10 841 400 | 8 740 112 ( 80,62 %) | 862 343 ( 7,954 %) | 80,62 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
PSOMAGEN, INC. 36.81% | 7 079 946 | 36.81% | 27 557 203 $ |
MACROGEN, INC. 7.44% | 806 492 | 7.44% | 13 508 926 $ |
LABGENOMICS CO., LTD. 1.80% | 1 335 288 | 1.80% | 3 010 287 $ |
17 828 431 | 3.98% | 2 442 495 $ |
Bedrijfsgegevens
Macrogen, Inc.
10/F, World Meridian Venture Center 254 Beotkkot-ro
08511, Seoul
+
http://www.macrogen.co.krSector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Kwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-3,33% | 149 mln. | |
+25,99% | 48,09 mld. | |
+47,41% | 40,62 mld. | |
-2,87% | 40,43 mld. | |
-6,20% | 28,36 mld. | |
+7,69% | 24,89 mld. | |
-19,03% | 19,01 mld. | |
+29,87% | 12,09 mld. | |
-0,74% | 11,88 mld. | |
-0,42% | 11,8 mld. |
- Beurs
- Aandelen
- Koers A038290
- Onderneming Macrogen, Inc.